Hagen Kennecke, MD, MHA, FRCPC
Dr Hagen Kennecke is an oncologist specializing in early detection, preventive therapy and treatment of gastrointestinal cancers—including bile duct, colon, small intestine, pancreas and rectal cancers, as well as appendix and neuroendocrine tumors. He serves as Section Chief and Chief Health Officer of the OHSU Knight–Legacy Health Cancer Collaborative. An active clinician-researcher and multiple-award recipient, Dr Kennecke chairs national and international GI oncology trials, sits on the NCI GI Steering Committee and has held leadership roles in the Rectal-Anal and Neuroendocrine Tumor Task Forces. He collaborates extensively with ASCO, NANETS, CCTG, SWOG, and LACNETS.
Financial relationships
-
Attribution:SelfType of financial relationship:OtherIneligible company:NateraTopic:honorarium < 5000 for presentationDate added:06/12/2025Date updated:06/12/2025Relationship end date:06/18/2025
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:NovartisTopic:Research support to institutionDate added:06/12/2025Date updated:06/12/2025Relationship end date:12/31/2025
-
Attribution:SelfType of financial relationship:OtherIneligible company:ExelixisTopic:honorarium for advisory boardDate added:06/12/2025Date updated:06/12/2025Relationship end date:12/31/2025